SCHEMBL508603

SCHEMBL508603

O=S(=O)(N/N=C/c1cc(Br)ccc1O)c1ccc(Br)cc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.85
ALDH1A1 P00352 3/20 0.85
RBM39 Q14498 1/20 0.85
GFER P55789 2/20 0.60
KMT2A Q03164 10/20 0.58
MEN1 O00255 6/20 0.58
POLB P06746 2/20 0.58
KDM4E B2RXH2 8/20 0.56
GAA P10253 1/20 0.56
CA12 O43570 2/20 0.56
CA1 P00915 2/20 0.56
CA2 P00918 2/20 0.56
CA9 Q16790 2/20 0.56
TDP1 Q9NUW8 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
NPSR1 Q6W5P4 1/20 0.52
LMNA P02545 3/20 0.51
HTT P42858 3/20 0.50
MITF O75030 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL508604 1.00 MAPT (0.85) MAPTALDH1A1RBM39GFERKMT2A
SCHEMBL13908103 0.92 MAPT (0.77) MAPTALDH1A1RBM39GFERKMT2A
SCHEMBL30480917 0.92 MAPT (0.77) MAPTALDH1A1RBM39GFERKMT2A
SCHEMBL10027946 0.92 MAPT (0.77) MAPTALDH1A1RBM39GFERKMT2A
SCHEMBL13908088 0.80 ALDH1A1 (0.81) MAPTALDH1A1RBM39KMT2AMEN1
SCHEMBL13908089 0.80 KMT2A (0.75) MAPTALDH1A1RBM39KMT2AMEN1
SCHEMBL10027945 0.78 ALDH1A1 (0.77) MAPTALDH1A1RBM39KMT2AMEN1
SCHEMBL14905767 0.77 ALDH1A1 (0.75) MAPTALDH1A1RBM39KMT2AMEN1
SCHEMBL13908086 0.76 ALDH1A1 (0.73) MAPTALDH1A1RBM39KMT2AMEN1
SCHEMBL13908239 0.76 ALDH1A1 (0.73) MAPTALDH1A1RBM39KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130143935-A1 STEM CELL DIFFERENTIATING AGENTS AND USES THEREFOR THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-06-06 US disclosed
US-20130143935-A1 STEM CELL DIFFERENTIATING AGENTS AND USES THEREFOR THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-06-06 US disclosed
US-20130143935-A1 STEM CELL DIFFERENTIATING AGENTS AND USES THEREFOR THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-06-06 US disclosed
US-8318951-B2 Stem cell differentiating agents and uses therefor THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-11-27 US disclosed
US-20120029200-A1 Stem Cell Differentiating Agents and Uses Therefor NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-02-02 US disclosed
US-20120029200-A1 Stem Cell Differentiating Agents and Uses Therefor NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-02-02 US disclosed
US-20120029200-A1 Stem Cell Differentiating Agents and Uses Therefor NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-02-02 US disclosed
US-7981935-B2 Stem cell differentiating agents and uses therefor THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2011-07-19 US disclosed
US-7981935-B2 Stem cell differentiating agents and uses therefor THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2011-07-19 US disclosed
US-7981935-B2 Stem cell differentiating agents and uses therefor THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2011-07-19 US disclosed
WO-2009038879-A2 STEM CELL DIFFERENTIATING AGENTS AND USES THEREFOR THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2009-03-26 WO disclosed
US-20090076103-A1 STEM CELL DIFFERENTIATING AGENTS AND USES THEREFOR THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2009-03-19 US disclosed
US-20090076103-A1 STEM CELL DIFFERENTIATING AGENTS AND USES THEREFOR THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2009-03-19 US disclosed
US-20090076103-A1 STEM CELL DIFFERENTIATING AGENTS AND USES THEREFOR THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029200-A1 Stem Cell Differentiating Agents and Uses Therefor MYADM, MCL1, NOTCH4 MAPT 4235/4885ALDH1A1 28/4885RBM39 3747/4885
US-20090076103-A1 STEM CELL DIFFERENTIATING AGENTS AND USES THEREFOR MYADM, MCL1, NOTCH4 MAPT 4235/4885ALDH1A1 28/4885RBM39 3747/4885
US-20130143935-A1 STEM CELL DIFFERENTIATING AGENTS AND USES THEREFOR MYADM, MCL1, NOTCH4 MAPT 4235/4885ALDH1A1 28/4885RBM39 3747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.